Geert-Jan Mulder MD
Managing Partner
Oxular is a clinical-stage therapeutic company developing new therapies for retinal diseases leveraging its proprietary formulation & delivery technology.
Oxular is committed to transforming the treatment paradigm for sight-threatening retinal disorders by providing safe, durable therapeutics that are precisely delivered to specific ocular tissues to control disease activity.
Industry
Biotech
Status
Past
Forbion team
Dmitrij Hristodorov PhD
General Partner